These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1616360)

  • 21. Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
    Overgaard K; Lindsay R; Christiansen C
    Clin Ther; 1995; 17(4):680-5. PubMed ID: 8565031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
    Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
    Luengo M; Pons F; Martinez de Osaba MJ; Picado C
    Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
    Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis.
    Kröger H; Arnala I; Alhava EM
    Calcif Tissue Int; 1992 Jan; 50(1):11-3. PubMed ID: 1739863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of calcitonin on bone and connective tissue metabolism in hemiplegic patients: a two-year prospective study.
    Uebelhart D; Hartmann DJ; Barbezat S; Mermillod B; Chantraine A
    Clin Rehabil; 1999 Oct; 13(5):384-91. PubMed ID: 10498345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of alendronate on bone mass after distal forearm fracture.
    van der Poest Clement E; Patka P; Vandormael K; Haarman H; Lips P
    J Bone Miner Res; 2000 Mar; 15(3):586-93. PubMed ID: 10750574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nasal administration of calcitonin in oophorectomized women: 2-year controlled double-blind study.
    Grigoriou O; Papoulias I; Vitoratos N; Papadias C; Konidaris S; Antoniou G; Chryssikopoulos A
    Maturitas; 1997 Dec; 28(2):147-51. PubMed ID: 9522322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.
    Deodhar A; Dore RK; Mandel D; Schechtman J; Shergy W; Trapp R; Ory PA; Peterfy CG; Fuerst T; Wang H; Zhou L; Tsuji W; Newmark R
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):569-74. PubMed ID: 20391513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment of established osteoporosis with intranasal calcitonin.
    Overgaard K; Christiansen C
    Calcif Tissue Int; 1991; 49 Suppl():S60-3. PubMed ID: 1933601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
    Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
    Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada M; Luna JD; Olea N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal salmon calcitonin in postmenopausal osteoporosis: effect of different therapeutic regimens on vertebral and peripheral bone density.
    Perrone G; Galoppi P; Valente M; Capri O; D'Ubaldo C; Anelli G; Zichella L
    Gynecol Obstet Invest; 1992; 33(3):168-71. PubMed ID: 1612530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double-blind study on the efficacy of long-term intermittent nasal elcatonin in recent postmenopausal women].
    Lozano-Tonkin C; Gracia A; Jareño J; Mercadal J
    An Med Interna; 2000 Aug; 17(8):399-405. PubMed ID: 11218985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.